These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32527111)

  • 21. Medical Management of Hepatocellular Carcinoma.
    Rich NE; Yopp AC; Singal AG
    J Oncol Pract; 2017 Jun; 13(6):356-364. PubMed ID: 28605614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons.
    Makary MS; Ramsell S; Miller E; Beal EW; Dowell JD
    World J Gastroenterol; 2021 Nov; 27(43):7462-7479. PubMed ID: 34887643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.
    Sapisochin G; Barry A; Doherty M; Fischer S; Goldaracena N; Rosales R; Russo M; Beecroft R; Ghanekar A; Bhat M; Brierley J; Greig PD; Knox JJ; Dawson LA; Grant DR
    J Hepatol; 2017 Jul; 67(1):92-99. PubMed ID: 28257902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage locoregional therapies for recurrent hepatocellular carcinoma.
    Criss CR; Makary MS
    World J Gastroenterol; 2023 Jan; 29(3):413-424. PubMed ID: 36688022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm.
    Au KP; Chok KSH
    World J Gastroenterol; 2018 Dec; 24(45):5081-5094. PubMed ID: 30568386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma.
    Shen PC; Chang WC; Lo CH; Yang JF; Lee MS; Dai YH; Lin CS; Fan CY; Huang WY
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):307-318. PubMed ID: 31175903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial.
    Chen LC; Chiou WY; Lin HY; Lee MS; Lo YC; Huang LW; Chang CM; Hung TH; Lin CW; Tseng KC; Liu DW; Hsu FC; Hung SK
    BMC Cancer; 2019 Mar; 19(1):275. PubMed ID: 30922261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
    Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
    Kallini JR; Gabr A; Ali R; Abouchaleh N; Riaz A; Baker T; Kulik L; Caicedo J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
    Liao M; Zhu Z; Wang H; Huang J
    Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
    Hong K; Georgiades CS; Geschwind JF
    Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Survival benefit with intraarterial techniques in hepatocellular carcinoma].
    Sangro B
    Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():95-101. PubMed ID: 25087719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
    Gui CH; Baey S; D'cruz RT; Shelat VG
    Eur J Surg Oncol; 2020 May; 46(5):763-771. PubMed ID: 31937433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma.
    Chua TC; Liauw W; Saxena A; Chu F; Glenn D; Chai A; Morris DL
    Liver Int; 2010 Feb; 30(2):166-74. PubMed ID: 19912531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoembolization of hepatocellular carcinoma.
    Ramsey DE; Kernagis LY; Soulen MC; Geschwind JF
    J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S211-21. PubMed ID: 12354839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.